Anzeige
Mehr »
Login
Montag, 17.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Neue Kursrakete – Deutsche Aktie im Höhenflug
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema SOLENO THERAPEUTICS

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
06.06.SOLENO THERAPEUTICS INC - 8-K, Current Report2
04.06.Soleno Therapeutics to join Russell 3000 Index2
22.05.Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 20242
22.05.Soleno Therapeutics to Participate in Upcoming Investor Conferences1
15.05.Soleno Therapeutics Stands with the Prader-Willi Syndrome Community1
09.05.Soleno Therapeutics GAAP EPS of -$0.59 misses by $0.223
09.05.SOLENO THERAPEUTICS INC - 10-Q, Quarterly Report2
07.05.SOLENO THERAPEUTICS INC - 8-K, Current Report1
03.05.Soleno Therapeutics announces pricing of $138M public offering1
03.05.Soleno Therapeutics Prices Public Offering Of 3 Mln Shares At $46/shr; Stock Down In After-hours1
03.05.Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock1
02.05.Soleno Therapeutics announces proposed common stock offering1
02.05.Soleno Therapeutics Announces Proposed Public Offering of Common Stock1
29.04.Why Soleno Therapeutics Stock Is Skyrocketing Today7
29.04.Soleno Therapeutics receives breakthrough therapy designation from FDA for PWS treatment8
22.04.SOLENO THERAPEUTICS INC - 8-K, Current Report3
19.04.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)83REDWOOD CITY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
► Artikel lesen
08.03.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)71REDWOOD CITY, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
► Artikel lesen
07.03.SOLENO THERAPEUTICS INC - 8-K, Current Report3
07.03.SOLENO THERAPEUTICS INC - 10-K, Annual Report-
Seite:  Weiter >>